Challenges in the Management of the Post-Transplant Period in Modern Transplantology

Authors

  • Matkarimov Bakhtiyorjon Khalmirzayevich Associate Professor, Department of General Surgery and Transplantology, Andijan State Medical Institute, Uzbekistan

DOI:

https://doi.org/10.51699/cajmns.v7i2.3123

Keywords:

Transplantation, Postoperative Care, Immunosuppression, Long-Term Follow-up, Patient Management, Multidisciplinary Care

Abstract

The post-transplant period is a defining moment in the evolution of contemporary transplantology and is largely responsible for long-term clinical outcomes and patient survival. While great progress in surgical techniques and perioperative management has been made and has led to better early post-transplant success, the success of transplantation is increasingly dependent on comprehensive and sustained management after surgery. The post-transplant period is marked by constant physiological adaptation, long-term immunosuppression, and the requirement for meticulous clinical surveillance, which is a complex and highly individualised period. This narrative review is an attempt to address the major problems that come with managing the post-transplant period in contemporary transplantology without a focus on a specific transplanted organ. The review synthesises the current state of the art that addresses some of the key aspects of post-transplant care, including the optimisation of immunosuppressive regimen, prevention and early identification of infectious complications, management of metabolic and systemic changes, patient adherence and the importance of multidisciplinary follow-up. The dynamic nature of post-transplant care and inherent limitations of the uniform management protocols are emphasised. The literature analysed points to the effect of long-term outcomes being strongly affected by individualised and patient-centred management approaches as opposed to standardised practices only. Immunosuppressive regimens require constant adjustment in order to maintain the balance of immunity yet minimise adverse effects. Infectious complications often have atypical clinical manifestations, underlining the necessity for active monitoring instead of treatment based on symptoms. In addition, metabolic disturbances and psychosocial factors become important contributors to morbidity and decreased quality of life among transplant recipients.

References

Morris PJ, Knechtle SJ. Kidney Transplantation: Principles and Practice. 7th ed. Philadelphia: Elsevier Saunders; 2014.

Fishman JA. Infection in solid-organ transplant recipients. New England Journal of Medicine. 2007;357(25):2601–2614.

Halloran PF. Immunosuppressive drugs for kidney transplantation. New England Journal of Medicine. 2004;351(26):2715–2729.

Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress? American Journal of Transplantation. 2004;4(1):1–8.

Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence. BMJ. 2005;331(7524):1064–1065.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses. PLoS Medicine. 2009;6(7):e1000097.

Fishman JA. Infection in solid-organ transplant recipients. New England Journal of Medicine. 2007;357(25):2601–2614.

Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Journal of Epidemiology and Community Health. 2006;60(5):367–372.

Halloran PF. Immunosuppressive drugs for kidney transplantation. New England Journal of Medicine. 2004;351(26):2715–2729.

Fishman JA. Infection in solid-organ transplant recipients. New England Journal of Medicine. 2007;357(25):2601–2614.

Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after transplantation. American Journal of Transplantation. 2003;3(2):178–185.

Dew MA, DiMartini AF, De Vito Dabbs A, et al. Adherence to the medical regimen during the first two years after transplantation. Transplantation. 2007;83(7):858–873.

Rodrigue JR, Mandelbrot DA, Hanto DW. A cross-sectional study of fatigue and sleep quality before and after transplantation. Clinical Transplantation. 2011;25(1):E13–E21.

Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress? American Journal of Transplantation. 2004;4(1):1–8.

Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. New England Journal of Medicine. 2007;357(25):2562–2575.

Kotton CN. Management of cytomegalovirus infection in solid organ transplantation. Nature Reviews Nephrology. 2010;6(12):711–721.

Opelz G, Döhler B. Influence of immunosuppressive regimens on graft survival. Transplantation. 2004;78(6):778–784.

Gordon EJ, Prohaska TR, Gallant MP, et al. Longitudinal analysis of transplant recipients’ self-care behaviors. American Journal of Transplantation. 2009;9(4):907–915.

Downloads

Published

2026-02-17

How to Cite

Khalmirzayevich, M. B. (2026). Challenges in the Management of the Post-Transplant Period in Modern Transplantology. Central Asian Journal of Medical and Natural Science, 7(2), 107–112. https://doi.org/10.51699/cajmns.v7i2.3123

Issue

Section

Articles